Strategic Education, Inc. (NasdaqGS:STRA), Cantel Medical Corp. (NYSE:CMD) Numbers By The Book

The Price to book ratio is the current share price of a company divided by the book value per share.  The Price to Book ratio for Strategic Education, Inc. NasdaqGS:STRA is 2.600604.  A lower price to book ratio indicates that the stock might be undervalued.  Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value.  The Price to Cash Flow for Strategic Education, Inc. (NasdaqGS:STRA) is 41.839587.  This ratio is calculated by dividing the market value of a company by cash from operating activities.  Additionally, the price to earnings ratio is another popular way for analysts and investors to determine a company’s profitability.  The price to earnings ratio for Strategic Education, Inc. (NasdaqGS:STRA) is -271.432713. This ratio is found by taking the current share price and dividing by earnings per share.

Investors may be taking a closer look stock market trends as we move into the second half of the year. Investors often have to grapple with the timing of selling a stock. After all the research is done and the portfolio is rounded out, the time will eventually come when decisions need to be made about whether to hold a winner or sell to lock up some profits. Often times, investors will hold on to a certain stock for much too long letting profits erode. Thinking that a hot stock will keep going higher and higher, may lead to lost profits further down the road. On the flip side, investors may become emotionally attached to a stock and not be able to part ways when the time has come. Avoiding the trap of waiting for a stock to bounce back and just break even can lead to the undoing of the portfolio. The belief that a particular stock will definitely come back to the buying level may leave investors out in the cold. Being able to keep the emotions in check and stay focused on the pertinent data, may help the stock portfolio thrive into the future.

Further, we can see that Strategic Education, Inc. (NasdaqGS:STRA) has a Shareholder Yield of -0.992748 and a Shareholder Yield (Mebane Faber) of -0.99775. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

Checking in on some valuation rankings, Strategic Education, Inc. (NasdaqGS:STRA) has a Value Composite score of 65. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 74.

Strategic Education, Inc. (NasdaqGS:STRA) has a current MF Rank of 8299. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

There are many different tools to determine whether a company is profitable or not.  One of the most popular ratios is the “Return on Assets” (aka ROA).  This score indicates how profitable a company is relative to its total assets.  The Return on Assets for Strategic Education, Inc. (NasdaqGS:STRA) is -0.041102.  This number is calculated by dividing net income after tax by the company’s total assets.  A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength.  The score helps determine if a company’s stock is valuable or not.  The Piotroski F-Score of Strategic Education, Inc. (NasdaqGS:STRA) is 5.  A score of nine indicates a high value stock, while a score of one indicates a low value stock.  The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings.  It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue.  The score is also determined by change in gross margin and change in asset turnover.

Volatility/PI
Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Strategic Education, Inc. (NasdaqGS:STRA) is 38.849100.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of Strategic Education, Inc. (NasdaqGS:STRA) is 37.646900.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 38.317300.

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Strategic Education, Inc. (NasdaqGS:STRA) for last month was 1.23342. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Strategic Education, Inc. (NasdaqGS:STRA) is 1.68320.

Investors may be interested in viewing the Gross Margin score on shares of Strategic Education, Inc. (NasdaqGS:STRA). The name currently has a score of 49.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

Investors paying close attention to the daily ebbs and flows of the stock market may be trying to guess which way momentum will swing into the next couple of months. Finding those stocks that are ready to ride the lightning may not be the easiest task with markets chugging along near all time highs. Investors may have to first figure out how much risk they want to take on when picking the next round of stocks. Once the risk appetite is determined, investors can start to decide whether they think it is best to go with the flow or buck the trend. Either way, paying attention to short-term and long-term price moves may help paint a clearer picture of what is happening with a particular stock. Maybe those stocks that were sure-fire winners a few months ago have lost some steam. Adjusting the portfolio may or may not be necessary, but knowing exactly what stocks are owned and how they are performing may help with additional decision making along the way. Of course nobody wants to be on the outside looking in as a stock is taking off, but there should be plenty of other opportunities in the future. Staying current with global economic conditions and keeping a finger on the pulse of the company during earnings season can help shed some light on where the stock may be headed next.  

The Price to Book ratio for Cantel Medical Corp. NYSE:CMD is 4.504956.  The Price to book ratio is the current share price of a company divided by the book value per share.  A lower price to book ratio indicates that the stock might be undervalued.  Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value.  The Price to Cash Flow for Cantel Medical Corp. (NYSE:CMD) is 28.778746.  This ratio is calculated by dividing the market value of a company by cash from operating activities.  Additionally, the price to earnings ratio is another popular way for analysts and investors to determine a company’s profitability.  The price to earnings ratio for Cantel Medical Corp. (NYSE:CMD) is 39.407648. This ratio is found by taking the current share price and dividing by earnings per share.

Making smart choices when picking stocks is typically a top priority for successful investors. For new investors with little market knowledge, this can be challenging. Figuring out how to start building the stock portfolio may take a lot of time and effort. When the individual investor decides that they want to manage their own portfolio and make their own trades, the journey has just begun. Many individuals will be tempted to pursue stock trading plans based on advice from friends, colleagues, or family members. Even though certain plans may work for someone else, there is no guarantee that success will transfer to others. Investors often need to do their own research in order to obtain as much knowledge as possible before diving in to the markets.

Checking in on some valuation rankings, Cantel Medical Corp. (NYSE:CMD) has a Value Composite score of 61. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 56.

Cantel Medical Corp. (NYSE:CMD) has a current MF Rank of 4933. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

Further, we can see that Cantel Medical Corp. (NYSE:CMD) has a Shareholder Yield of 0.008017 and a Shareholder Yield (Mebane Faber) of -0.01591. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength.  The score helps determine if a company’s stock is valuable or not.  The Piotroski F-Score of Cantel Medical Corp. (NYSE:CMD) is 5.  A score of nine indicates a high value stock, while a score of one indicates a low value stock.  The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings.  It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue.  The score is also determined by change in gross margin and change in asset turnover.

Investors may be interested in viewing the Gross Margin score on shares of Cantel Medical Corp. (NYSE:CMD). The name currently has a score of 3.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

Volatility/PI
Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Cantel Medical Corp. (NYSE:CMD) is 36.067100.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of Cantel Medical Corp. (NYSE:CMD) is 36.946500.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 33.224500.

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Cantel Medical Corp. (NYSE:CMD) for last month was 1.01993. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Cantel Medical Corp. (NYSE:CMD) is 0.56074.

There are many different tools to determine whether a company is profitable or not.  One of the most popular ratios is the “Return on Assets” (aka ROA).  This score indicates how profitable a company is relative to its total assets.  The Return on Assets for Cantel Medical Corp. (NYSE:CMD) is 0.082998.  This number is calculated by dividing net income after tax by the company’s total assets.  A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.

There are so many different aspects to address when attempting to trade the stock market. With all the information available, it can become stressful trying to make sense of everything. Investors who are able to prioritize useful data may be able to make better big picture decisions. Even when all the research is done and the numbers have been crunched, investors still may find themselves forced with the tough decision of when to buy a specific equity. Doing the due diligence and being prepared can be a great asset when forced into a tough situation. Knowing when to pounce on an opportunity can be just as important as knowing when to exit a bad trade. As humans, investors will always be prone to making mistakes. Investors who are able to identify and learn from those mistakes might find themselves in a much better position over the long run.

Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately!

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.